Medicines for Europe, a manufacturers of generic and biosimilar trade group, today presented five trade policy ...

Pharma majors AbbVie and Roche were both trading lower early Tuesday after top-line results were announced from the global ...

Some 55 attorneys general (AGs), representing all eligible states and US territories, have agreed to sign on to a $7.4 ...

Australian biotech CSL has announced that the US Food and Drug Administration (FDA) has approved Andembry (garadacimab-gxii), ...

US pharma major Eli Lilly (today announced a definitive agreement to acquire Verve Therapeutics, a Boston-based ...

South Korea’s clinical-stage biotech D&D Pharmatech saw its share leap as much as 30% as it revealed “remarkably positive” ...

US trade association PhRMA (Pharmaceutical Research and Manufacturers of America) has cited a new IQVIA study that found that ...

Shares of USA-based NextCure slumped 26% to $0.50 on Monday, after the company announced a strategic partnership with ...

Israel’s Teva Pharmaceutical Industries and Shanghai Fosun Pharmaceutical have entered a strategic partnership for the ...

Aquestive Therapeutics today announced that the US Food and Drug Administration (FDA) has accepted the company’s New Drug Application (NDA) for Anaphylm sublingual epinephrine film under development ...

Cambridge, UK-based Maxion Therapeutics today announced the appointment of Dr Stefan Härtle as chief development officer, ...

Scientists at The Institute of Cancer Research, London, claim to have discovered what may cause some treatments to stop working in people living with bowel cancer.